GlassScriptPhysician profile
Lee Perry Gerson
NPI 1801144332
$19,012.41
in general payments reported to CMS, 2019-2025
20 companies · $4,006 in 2025
The $4,006 reported for 2025 was more than what 79% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2021: $276 · 2022: $5,098 · 2023: $7,696 · 2024: $1,801 · 2025: $4,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,057 · Travel and Lodging: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,750.00 |
| Food and Beverage | $1,057.33 |
| Travel and Lodging | $695.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,904.20 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Atricure, INC. | $294.33 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| On Target Laboratories, INC | $161.05 | 2025 | Cytalux |
| Davol INC. | $153.10 | 2025 | Arista, Surgiphor |
| Covidien LP | $72.45 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $59.52 | 2024-2025 | Tagrisso |
| Stryker Corporation | $57.84 | 2022 | |
| Depuy Synthes Sales INC. | $40.50 | 2025 | Zipfix |
| Medtronic, INC. | $36.02 | 2024-2025 | Signia |
| Merck Sharp & Dohme LLC | $30.83 | 2025 | Keytruda |
| Boston Scientific Corporation | $30.44 | 2024 | Spyglass Discover |
| Baxter Healthcare | $29.53 | 2024 | Tisseel |
| Regeneron Healthcare Solutions, INC. | $29.29 | 2025 | Libtayo |
| Kls-Martin L.P. | $19.70 | 2024 | |
| Integra Lifesciences Corporation | $18.21 | 2024 | Integra, Surgimend, Omnigraft |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $17.20 | 2024 | |
| Hydrofera LLC | $16.29 | 2025 | Sorbact Other |
| Tela Bio, INC. | $15.84 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Access Pro Medical, LLC | $13.50 | 2025 | Matriderm |
| Olympus America INC. | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Gerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.